Critical Residue That Promotes Protein Dimerization: a Story of Partially Exposed Phe25 in 14-3-3σ
Overview
Medical Informatics
Affiliations
Many proteins exist and function as oligomers. While hydrophobic interactions have been recognized as the major driving force for oligomerization, detailed molecular mechanisms for the assembly are unknown. Here, we used 14-3-3σ as a model protein and investigated the role of hydrophobic residues at the dimeric interface using MD simulations and coimmunoprecipitations. We found that a half-exposed and half-buried residue in the interface, Phe(25), plays a more important role in promoting homodimerization than the hydrophobic core residues by organizing both favorable hydrophobic and hydrophilic interactions. Phe(25) is critical in packing and stabilizing hydrophobic core residues. We conclude that the structural stability of hydrophobic cores is critical for a stable homodimer complex and this stable property can be bestowed by residues outside of hydrophobic core. The important organizing activity of Phe(25) for homodimerization of 14-3-3σ originates from its unique physical location, rigidity, size, and hydrophobicity. Thus, hydrophobic residues that are not deeply buried at the oligomeric interface may play important but different roles from the buried core residues and they may promote oligomerization by organizing co-operativity of core and other residues for favorable hydrophobic and electrostatic interactions.
Novel Cellular Functions of ATR for Therapeutic Targeting: Embryogenesis to Tumorigenesis.
Biswas H, Makinwa Y, Zou Y Int J Mol Sci. 2023; 24(14).
PMID: 37511442 PMC: 10380702. DOI: 10.3390/ijms241411684.
In Silico Studies on GCP-Lys-OMe as a Potential 14-3-3σ Homodimer Stabilizer.
Aljabal G, Yap B Pharmaceuticals (Basel). 2022; 15(10).
PMID: 36297403 PMC: 9609495. DOI: 10.3390/ph15101290.
Biswas H, Zhao S, Makinwa Y, Bassett J, Musich P, Liu J Front Cell Dev Biol. 2022; 10:826576.
PMID: 35721505 PMC: 9204103. DOI: 10.3389/fcell.2022.826576.
YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins.
Qiao S, Wang W, Yi C, Xu Q, Wang W, Shi J Cancers (Basel). 2022; 14(7).
PMID: 35406384 PMC: 8996997. DOI: 10.3390/cancers14071611.
14-3-3σ and Its Modulators in Cancer.
Aljabal G, Yap B Pharmaceuticals (Basel). 2020; 13(12).
PMID: 33287252 PMC: 7761676. DOI: 10.3390/ph13120441.